Trial Details

COMPLETED
Basic Information
Clinical ID c4616
Identifier NCT00259155
Trial Title Rifaximin for the Treatment of Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: Rifaximin
Participant Information
Sponsor Cedars-Sinai Medical Center
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2003-07
Primary Completion Date 2007-01
Completion Date 2007-01